Parkure Overview

  • Founded
  • 2014

Founded
  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $126K

  • Investors
  • 2

Parkure General Information

Description

Provider of drug discovery services intended to find a cure for Parkinson's disease. The company's services include drug testing procedures by using fruit flies, enabling the medical industry to find a treatment that stops the nerve cell degeneration process.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • Edinburgh
  • Scotland, United Kingdom
+44 07811 000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Parkure Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 16-Jul-2020 $126K 00000 00.000 Completed Generating Revenue
5. Secondary Transaction - Private 01-Jan-2019 00000 Completed Generating Revenue
4. Early Stage VC 30-Jun-2016 00000 Completed Generating Revenue
3. Angel (individual) 03-Apr-2015 00000 00000 00.000 Completed Generating Revenue
2. Grant 01-Dec-2014 $118K Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Parkure’s complete valuation and funding history, request access »

Parkure Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 00,000 00.000000 00.00 00.00 00 00.00 00.000
To view Parkure’s complete cap table history, request access »

Parkure Patents

Parkure Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201815773-D0 Screening assay using drosophila lines Inactive 02-Mar-2016 00000000000
GB-201603654-D0 Screening assay Inactive 02-Mar-2016 00000000000
GB-2563551-A Screening assay using drosophila lines Inactive 02-Mar-2016 G01N33/5085 0

Parkure Executive Team (1)

Name Title Board Seat Contact Info
Lysimachos Zografos Ph.D Chief Executive Officer
To view Parkure’s complete executive team members history, request access »

Parkure Board Members (3)

Name Representing Role Since
J. Douglas Armstrong Ph.D Parkure Board Member 000 0000
Ron James Ph.D Parkure Board Member 000 0000
R. Wayne Davies Ph.D Self Board Member 000 0000
To view Parkure’s complete board members history, request access »

Parkure Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
The Scottish Government Government 000 0000 000000 0
LAUNCH.ed University 000 0000 000000 0
To view Parkure’s complete investors history, request access »